ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis

Li,Minghua; Tian,Linli; Yao,Hongchao; Lu,Jianguang; Ge,Jingchun; Guo,Yan; Liu,Ming; Xiao,Hui

doi:10.3892/or.2014.3150

ASAP1 mediates the invasive phenotype of human laryngeal squamous cell carcinoma to affect survival prognosis

Authors:
- Minghua Li
- Linli Tian
- Hongchao Yao
- Jianguang Lu
- Jingchun Ge
- Yan Guo
- Ming Liu
- Hui Xiao
View Affiliations

Affiliations: Service of Head and Neck Surgery, Department of Otolaryngology - Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Service of Laryngology, Department of Otolaryngology - Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
Published online on: April 23, 2014 https://doi.org/10.3892/or.2014.3150
Pages: 2676-2682

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

ASAP1 helps regulate cellular structures such as actin cytoskeletal remodeling and focal adhesions that have a pivotal function in tumor progression. Overexpression of ASAP1 has proven to be a malignant indicator for a variety of tumors. To further determine the potential involvement of ASAP1 in laryngeal squamous cell carcinoma (LSCC), we evaluated the expression levels of ASAP1 by quantitative real-time reverse-transcriptase polymerase chain reaction (qRT-PCR) and immunohistochemistry in tissue samples of 64 LSCC patients. We then analyzed and correlated the results with clinicopathological features. Furthermore, we used small interfering RNA (siRNA) to inhibit ASAP1 expression in vitro. The potential function of ASAP1 in invasiveness was evaluated in the Hep-2 LSCC cell line. Kaplan-Meier method was utilized to determine the association of ASAP1 expression with survival of patients. We showed that ASAP1 was upregulated in primary LSCC tumors and was correlated with lymph node metastasis and clinical tumor stage. Similarly, higher levels of ASAP1 were detected in the Hep-2 cell line compared to the 16 human bronchial epithelial (16HBE) cell line. ASAP1 expression was downregulated by lentiviral vector transfection containing siRNA in vitro. The invasive potential of these cells was found to be significantly suppressed, while expression levels of Rac1 and Cdc42 positively correlated with the inhibition of ASAP1 expression. In Kaplan-Meier overall survival curves, higher ASAP1 mRNA levels were found to be associated with a shorter progression-free survival trend. Based on these results, ASAP1 appears to contribute to the malignant mechanism of LSCC and may represent a significant prognostic marker for LSCC patients.

View Figures

View References

1	Inoue H and Randazzo PA: Arf GAPs and their interacting proteins. Traffic. 8:1465–1475. 2007. View Article : Google Scholar
2	Buffart TE, Coffa J, Hermsen MA, et al: DNA copy number changes at 8q11–24 in metastasized colorectal cancer. Cell Oncol. 27:57–65. 2005.
3	Martin RK and Jackson TR: Centaurin β4 in cancer. Biochem Soc Trans. 33:1282–1284. 2005.
4	Inoue H, Ha VL, Prekeris R and Randazzo PA: Arf GTPase-activating protein ASAP1 interacts with Rab11 effector FIP3 and regulates pericentrosomal localization of transferrin receptor-positive recycling endosome. Mol Biol Cell. 19:4224–4237. 2008. View Article : Google Scholar
5	Jian X, Brown P, Schuck P, et al: Autoinhibition of Arf GTPase-activating protein activity by the BAR domain in ASAP1. J Biol Chem. 284:1652–1663. 2009. View Article : Google Scholar : PubMed/NCBI
6	Liu Y, Loijens JC, Martin KH, Karginov AV and Parsons JT: The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol Biol Cell. 13:2147–2156. 2002. View Article : Google Scholar : PubMed/NCBI
7	Liu Y, Yerushalmi GM, Grigera PR and Parsons JT: Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling. J Biol Chem. 280:8884–8892. 2005. View Article : Google Scholar : PubMed/NCBI
8	Brown MT, Andrade J, Radhakrishna H, et al: ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src. Mol Cell Biol. 18:7038–7051. 1998.PubMed/NCBI
9	Bharti S, Inoue H, Bharti K, et al: Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol. 27:8271–8283. 2007. View Article : Google Scholar : PubMed/NCBI
10	King FJ, Hu E, Harris DF, Sarraf P, Spiegelman BM and Roberts TM: DEF-1, a novel Src SH3 binding protein that promotes adipogenesis in fibroblastic cell lines. Mol Cell Biol. 19:2330–2337. 1999.PubMed/NCBI
11	Kam JL, Miura K, Jackson TR, et al: Phosphoinositide-dependent activation of the ADP-ribosylation factor GTase-activating protein ASAP1. Evidence for the pleckstrin homology domain functioning as an allosteric site. J Biol Chem. 275:9653–9663. 2000. View Article : Google Scholar
12	Randazzo PA, Andrade J, Miura K, et al: The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. Proc Natl Acad Sci USA. 97:4011–4016. 2000. View Article : Google Scholar : PubMed/NCBI
13	Nie Z and Randazzo PA: Arf GAPs and membrane traffic. J Cell Sci. 119:1203–1211. 2006. View Article : Google Scholar : PubMed/NCBI
14	Donaldson JG and Jackson CL: ARF family G protein and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol. 12:362–375. 2011. View Article : Google Scholar : PubMed/NCBI
15	Onodera Y, Hashimoto S, Hashimoto A, et al: Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J. 24:963–973. 2005. View Article : Google Scholar : PubMed/NCBI
16	Muller T, Stein U and Poletti A: ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients. Oncogene. 29:2393–2403. 2010. View Article : Google Scholar : PubMed/NCBI
17	Ehlers JP, Worley L, Onken MD and Harbour JW: DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res. 11:3609–3613. 2005. View Article : Google Scholar
18	Lin D, Watahiki A, Bayani J, et al: ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res. 68:4352–4359. 2008. View Article : Google Scholar
19	Randazzo PA, Inoue H and Bharti S: Arf GAPs as regulators of the actin cytoskeleton. Biol Cell. 99:583–600. 2007. View Article : Google Scholar : PubMed/NCBI
20	Furman C, Short SM, Subramanian RR, Zetter BR and Roberts TM: DEF-1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility through a GAP-dependent mechanism. J Biol Chem. 277:7962–7969. 2002. View Article : Google Scholar : PubMed/NCBI
21	Bar-Sagi D and Hall A: Ras and Rho GTPases: a family reunion. Cell. 103:227–238. 2000. View Article : Google Scholar : PubMed/NCBI
22	Wagner AC and Williams JA: Low molecular weight GTP-binding proteins: molecular switches regulating diverse cellular functions. Am J Physiol. 266:G1–G14. 1994.PubMed/NCBI
23	Waschke J, Burger S, Curry FR, Drenckhahn D and Adamson RH: Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier. Histochem Cell Biol. 125:397–406. 2006. View Article : Google Scholar : PubMed/NCBI
24	Lamarche N, Tapon N, Stowers L, et al: Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell. 87:519–529. 1996. View Article : Google Scholar : PubMed/NCBI
25	Yang FC, Atkinson SJ, Gu Y, et al: Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci USA. 98:5614–5618. 2001. View Article : Google Scholar : PubMed/NCBI
26	Huang M, Satchell L, Duhadaway JB, Prendergast GC and Laury-Kleintop LD: RhoB links PDGF signaling to cell migration by coordinating activation and localization of Cdc42 and Rac. J Cell Biochem. 112:1572–1584. 2011. View Article : Google Scholar : PubMed/NCBI
27	Kaibuchi K, Kuroda S and Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem. 68:459–486. 1999. View Article : Google Scholar : PubMed/NCBI
28	Engers R, Springer E, Michiels F, Collard JG and Gabbert HE: Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem. 276:41889–41897. 2001. View Article : Google Scholar : PubMed/NCBI
29	Filipenko NR, Attwell S, Roskelley C and Dedhar S: Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via α-PIX. Oncogene. 24:5837–5849. 2005.PubMed/NCBI
30	Fidler IJ: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3:453–458. 2003.
31	Foley R, Hollywood D and Lawler M: Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease. Endocr Relat Cancer. 11:477–488. 2004. View Article : Google Scholar : PubMed/NCBI
32	Miyata M, Raven JF, Baltzis D, Koromilas AE and Sabe H: IRES-mediated translational control of AMAP1 expression during differentiation of monocyte U937 cells. Cell Cycle. 7:3273–3281. 2008. View Article : Google Scholar : PubMed/NCBI
33	Jackson TR, Brown FD, Nie Z, et al: ACAPs are arf6 GTPase-activating proteins that function in the cell periphery. J Cell Biol. 151:627–638. 2000. View Article : Google Scholar : PubMed/NCBI
34	Kondo A, Hashimoto S, Yano H, Nagayama K, Mazaki Y and Sabe H: A new paxillin-binding protein, PAG3/Papα/KIAA0400, bearing an ADP-ribosylation factor GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions and cell migration. Mol Biol Cell. 11:1315–1327. 2000.PubMed/NCBI
35	Sabe H, Hashimoto S, Morishige M, et al: The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic. 10:982–993. 2009. View Article : Google Scholar : PubMed/NCBI
36	Nam JM, Onodera Y, Mazaki Y, Miyoshi H, Hashimoto S and Sabe H: CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J. 26:647–656. 2007. View Article : Google Scholar : PubMed/NCBI
37	Onodera Y, Nam JM, Hashimoto A, et al: Rab5c promotes AMAP1-PRKD2 complex formation to enhance beta1 integrin recycling in EGF-induced cancer invasion. J Cell Biol. 197:983–996. 2012. View Article : Google Scholar : PubMed/NCBI
38	Ridley AJ, Paterson HF, Johnston CL, Diekmann D and Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:401–410. 1992. View Article : Google Scholar : PubMed/NCBI
39	Chianale F, Cutrupi S, Rainero E, et al: Diacylglycerol kinase-alpha mediates hepatocyte growth factor-induced epithelial cell scatter by regulating Rac activation and membrane ruffling. Mol Biol Cell. 18:4859–4871. 2007. View Article : Google Scholar : PubMed/NCBI
40	Nobes CD and Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:53–62. 1995. View Article : Google Scholar